tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kevin Ellich, 20 are a BUY (35.71%), 32 are a HOLD (57.14%), 4 are a SELL (7.14%).
Analyst Kevin Ellich, carries an average stock price target met ratio of 95.63% that have a potential upside of 19.01% achieved within 340 days. Previously, Kevin Ellich worked at CRAIG HALLUM, PIPER SANDLER.
Kevin Ellich’s has documented 135 price targets and ratings displayed on 17 stocks. The coverage was on Healthcare, Financial Services, Industrials sectors.
Most recent stock forecast was given on AMED, Amedisys at 31-Oct-2019.
Analyst best performing recommendations are on AMED (AMEDISYS).
The best stock recommendation documented was for PETS (PETMED EXPRESS) at 10/17/2019. The price target of $20 was fulfilled within 4 days with a profit of $3.63 (22.17%) receiving and performance score of 55.44.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 21-Feb-2023
$100
$-0.99 (-0.98%)
$100
11 months 16 days ago
(16-Apr-2025)
2/3 (66.67%)
$8.09 (8.80%)
307
Hold Since 21-Apr-2023
$101
$0.01 (0.01%)
$101
11 months 28 days ago
(04-Apr-2025)
2/10 (20%)
$9.11 (9.91%)
419
Hold Since 27-Oct-2022
1 years 22 days ago
(10-Mar-2025)
5/10 (50%)
$12.13 (9.49%)
99
Hold Since 22-Oct-2019
$101
$0.01 (0.01%)
$103
1 years 28 days ago
(04-Mar-2025)
4/11 (36.36%)
$8.9 (9.66%)
18
Buy Since 03-Aug-2018
$100
$-0.99 (-0.98%)
$100
1 years 3 months 2 days ago
(30-Dec-2024)
9/15 (60%)
$9.51 (10.51%)
135
What Year was the first public recommendation made by Kevin Ellich?
